TP53 mutations were detected in eleven PSC-associated CCAs and three PSC-associated dysplasia samples; in particular, one PSC-associated CCA sample carried two different TP53 missense mutations and one PSC-associated dysplasia sample showed the combination of a splice site and a TP53 missense mutation. This evidence concerns the gene TP53 and cholangiocarcinoma.